Health Care/Hospital
Grand launch | Sanyou Bio monkeypox antibody made a great breakthrough
SHANGHAI, Sept. 4, 2024 /PRNewswire/ -- On August 28, 2024, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. announced the launch of 65 kinds of monkeypox antibodies, antigens and cell lines, which has won wide praise from the public. Monkeypox human antibody, as the core product launched by Sanyo...
2024-09-05 08:00
1058
Accorto Regulatory Solutions joins GINN to Further Tobacco Harm Reduction Mission
RICHMOND, Va., Sept. 4, 2024 /PRNewswire/ -- Accorto Regulatory Solutions, an industry-leading regulatory compliance firm specializing in helping organizations bring their innovative FDA-regulated products to market, is proud to formally announce its membership in the Global Institute for Novel N...
2024-09-04 23:00
1387
Carterra unveils its most sensitive biosensor platform; Carterra Ultra™ ushers in a new frontier in fragment and small molecule drug discovery
The new instrument enables high-throughput small and large molecule characterization in traditional and AI-driven workflows SALT LAKE CITY, Sept. 4, 2024 /PRNewswire/ -- Carterra Inc., the world leader in innovative technologies enabling high-throughput biology, today has launched Carterra Ultra...
2024-09-04 23:00
1910
TraceLink's Magnum Release of its Opus Platform Will Revolutionize Supply Chain Management by Enabling All Businesses to Digitalize their End-to-End Supply Networks
With real-time information from all supply chain partners, Supply Chain Managers can reduce inventory and stock-out while improving service levels and lead times BOSTON, Sept. 4, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the ...
2024-09-04 22:00
1552
Harrison.ai launches world leading AI model to transform healthcare
Harrison.rad.1 significantly outperforms other major models on radiology tasks The new model is being made accessible to select healthcare professionals and regulators to open up the conversation on responsible use of AI in healthcare SYDNEY, Sept. 4, 2024 /PRNewswire/ -- Healthcare AI technolog...
2024-09-04 21:30
1815
Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical Study
Multicenter Clinical Study Demonstrates Benefits of Regenity's Novel Crosslinked Collagen Membrane Compared to Geistlich Bio-Gide® Collagen Membrane and Enables Launch intoChina PARAMUS, N.J., Sept. 4, 2024 /PRNewswire/ -- Regenity Biosciences, a global leader in regenerative medicine and Linden...
2024-09-04 21:00
1239
Phesi Receives Frost & Sullivan's Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform
Phesi's Trial Accelerator™ Platform empowers trial sponsors to make informed decisions swiftly, expediting drug development timelines while upholding the highest standards of data integrity and patient-centricity SAN ANTONIO, Sept. 4, 2024 /PRNewswire/ -- Frost & Sullivan has recognized Phesi wi...
2024-09-04 21:00
1221
Waterdrop Inc. Announces Second Quarter 2024 Unaudited Financial Results and a Special Cash Dividend, Net profit rises 306.9% year-on-year
BEIJING, Sept. 4, 2024 /PRNewswire/ -- On September 4, 2024, Waterdrop Inc. (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, unveiled its unaudited financial results for the second quarter of 2024 endedJune 30, 2024. During t...
2024-09-04 20:41
3133
Samyang Corporation Completes Specialty Plant, Establishes Korea's Largest Allulose Production Facility
* Completion of the Specialty (high-functional ingredients) Plant producing allulose and prebiotics ingredients * Total floor area of 22,150m2, annual specialty ingredients production capacity of 25,000 tons, with an investment of approximatelyKRW 140 billion * Largest allulose production...
2024-09-04 20:30
2234
LakeShore Biopharma Announces Leadership Transitions
GAITHERSBURG, Md., Sept. 4, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for ...
2024-09-04 20:00
1181
LakeShore Biopharma Announces Leadership Transitions
GAITHERSBURG, Md., Sept. 4, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for ...
2024-09-04 20:00
1387
Waterdrop Inc. Announces Second Quarter 2024 Unaudited Financial Results and a Special Cash Dividend
BEIJING, Sept. 4, 2024 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the three and six months endedJune...
2024-09-04 18:18
2613
21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin: 21st.BIO customers can now enter the U.S. market with their own production using 21st.BIO technology
* 21st.BIO has earned a self-affirmed GRAS status for its animal-free beta-lactoglobulin ingredient, which customers can now launch inthe United States market. * 21st.BIO is helping customers bring products to market at an unprecedented pace, from initiation of development to market approval ...
2024-09-04 15:47
1349
HKBU develops Chinese medicine for ulcerative colitis approved by National Medical Products Administration for clinical trial
HONG KONG, Sept. 4, 2024 /PRNewswire/ -- The Centre for Chinese Herbal Medicine Drug Development (CDD) at Hong KongBaptist University (HKBU) has achieved a significant milestone in developing a novel Chinese herbal formulation for ulcerative colitis remission maintenance. Following a submission o...
2024-09-04 15:13
1396
3 in 5 Aspiring Entrepreneurs in Asia Pacific Planning to Start a Small Business in the Next 18 Months - Herbalife Survey
Untapped opportunities seen in health and wellness for aspiring entrepreneurs HONG KONG, Sept. 4, 2024 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released findings from itsAsia Pacific Business of Wellness Survey,which revealed that despite concerns abou...
2024-09-04 11:43
7266
Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma
SAN FRANCISCO and SUZHOU, China, Sept. 4, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...
2024-09-04 08:00
3953
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
MELBOURNE, Australia, Sept. 4, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Company's IPAX-1 Phase I study has been published inNeuro-Oncology Advances, confirming the safety and tolerability profile, and early efficacy of TLX101 thera...
2024-09-04 06:57
1827
Acepodia Enters Strategic Clinical Collaboration with Pfizer to Accelerate Development of Antibody-Cell Conjugation-Based Cell Therapies in Autoimmune Diseases
* Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyond oncology into autoimmune diseases * Pfizer Ignite will also provide strategic advisory support for Acepodia's ongoing clinical programs,...
2024-09-04 05:00
1590
Frost Radar™ Positions 14 Top Growth & Innovation Leaders in Global Healthcare Data Interoperability
Frost & Sullivan's Benchmarking System Highlights Leading Companies Poised for Growth and Advancing Healthcare Interoperability SAN ANTONIO, Sept. 4, 2024 /PRNewswire/ -- The healthcare data interoperability market is expected to reach$19.28 billion by 2028, growing at a compound annual growth ...
2024-09-04 01:45
1578
BoomerangFX Expands Software and Marketing Solutions into the Philippines and Puerto Rico, Signaling Focused Growth in Asia and Latin America
Following strong growth in the USA, Canada, and Australia, BoomerangFX enters Asia and Latin American markets to meet rising global demand for Aesthetic Medicine, Holistic Wellness, Women's Health, and Specialty Vision Care. MIAMI, Sept. 3, 2024 /PRNewswire/ -- BoomerangFX, a global SaaS (softwar...
2024-09-03 23:10
1516
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5310
